Michael Secora - Aug 15, 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Financial Officer
Signature
/s/Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Aug 15, 2024
Transactions value $
-$80,026
Form type
4
Date filed
8/19/2024, 07:09 PM
Previous filing
Aug 15, 2024
Next filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Tax liability -$80K -12K -0.88% $6.69 1.35M Aug 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RXRX Stock Option (Right to Buy) 574K Aug 15, 2024 Class A Common Stock 0 $2.22 Direct F2
holding RXRX Stock Option (Right to Buy) 685K Aug 15, 2024 Class A Common Stock 0 $2.22 Direct F3
holding RXRX Stock Option (Right to Buy) 3.91K Aug 15, 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 117K Aug 15, 2024 Class A Common Stock 0 $11.40 Direct F4
holding RXRX Stock Option (Right to Buy) 405K Aug 15, 2024 Class A Common Stock 0 $8.55 Direct F5
holding RXRX Stock Option (Right to Buy) 348K Aug 15, 2024 Class A Common Stock 0 $10.09 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
F2 The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events.
F3 The option, originally for 1,125,000 shares, vests as to one forty-eighth (1/48th) of the shares subject to the award one month after March 1, 2020, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F6 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.